Aveanna Healthcare Holdings Inc.AVAHNASDAQ
Loading

Latest News

Aveanna Healthcare Holdings: Recent Results Have Me More Optimistic (Rating Upgrade)
seekingalpha.com

Aveanna Healthcare Holdings: Recent Results Have Me More Optimistic (Rating Upgrade)

Aveanna Healthcare Holdings (AVAH) is upgraded to Buy, reflecting improved profitability and resilient demand for home healthcare services. AVAH's Q4 2025 net income surged, but adjusted EPS was $0.17 due to one-time tax benefits and merger costs. FY 2026 revenue guidance of $2.54–$2.56 billion disappointed, while adjusted EBITDA guidance slightly exceeded consensus.

Aveanna Healthcare Q4 Earnings Call Highlights
defenseworld.net

Aveanna Healthcare Q4 Earnings Call Highlights

Aveanna Healthcare (NASDAQ: AVAH) reported fourth-quarter and full-year 2025 results that management said reflected continued progress in its preferred payer strategy, improving labor trends, and rate initiatives across its home- and community-based care platform. Executives also provided initial commentary on a newly announced acquisition and issued 2026 guidance that excludes any contribution from the pending deal.

Aveanna Healthcare (AVAH) to Release Quarterly Earnings on Thursday
defenseworld.net

Aveanna Healthcare (AVAH) to Release Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ: AVAH - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Investors may review the information on the company's upcoming Q4 2025 earning report for the latest details on

Aveanna's Heartways Program Receives CHAP Disease Program Certification
globenewswire.com

Aveanna's Heartways Program Receives CHAP Disease Program Certification

ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care in the home, announced today that Aveanna Home Health and Hospice, a division of Aveanna Healthcare, has been awarded a Disease Program Certification for Heart Failure under the CHAP Disease Program Standards. CHAP certification demonstrates that Aveanna Home Health and Hospice meets the industry's highest nationally recognized standards.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Brokerages
defenseworld.net

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) has received a consensus rating of "Hold" from the eleven research firms that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target

Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
globenewswire.com

Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance

ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced updated full year guidance for fiscal year 2025 (year ended January 3, 2026) and its initial full year guidance for fiscal year 2026 (year ending January 2, 2027).

Financial Review: Aveanna Healthcare (NASDAQ:AVAH) versus Elanco Animal Health (NYSE:ELAN)
defenseworld.net

Financial Review: Aveanna Healthcare (NASDAQ:AVAH) versus Elanco Animal Health (NYSE:ELAN)

Aveanna Healthcare (NASDAQ: AVAH - Get Free Report) and Elanco Animal Health (NYSE: ELAN - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Ratings This is a breakdown of